Daniel Petree

Daniel H.
Petree was the founder of P2 Partners LLC, founded in 2000, where the title held was Director from 2000 to 2012.
Mr. Petree was the founder of Four Oaks Partners LLC, founded in 2012, with the title of Managing Director from 2012 to 2021.
Mr. Petree was the founder of Four Oaks Partners Consulting LLC, founded in 2012, holding the title of Member from 2012 to 2021.
Current jobs include Independent Director at Sutro Biopharma, Inc. since 2009 and Director & Head-Corporate Development at Lipidio Pharmaceuticals, Inc. Former jobs include Chairman at Lpath, Inc. from 2008 to 2016; Director at Cypress Bioscience, Inc. from 2004 to 2011; Director at Biocept, Inc. from 2009 to 2013; Director at Koronis Pharmaceuticals, Inc.; Director at NKT Therapeutics, Inc.; President & Chief Operating Officer at Axys Pharmaceuticals, Inc. from 1993 to 1999; Vice President-Health Care Group at Montgomery Securities, Inc.; Vice President-Business Development at TSI Corp from 1991 to 1993; Chief Financial Officer & Executive Vice President at Arris Pharmaceuticals Corp.; and Principal at Heller Ehrman White & McAuliffe LLP.
Education includes an undergraduate degree from Stanford University conferred in 1977 and a graduate degree from The University of Michigan Law School conferred in 1981.